The structural requirements in the ACTH molecule for evocation of the glycolytic response Lys8,Phe9 analogues. Replacement of the glycine moiety in position 10 with l-alanine, d-alanine, \ g = b \ \ x = r e q -\ alanine or \g=a\-aminoisobutyric acid had little or no effect on steroidogenic or glycolytic capacity, although potency was reduced with all substitutions excepting l-alanine.
tion of a nitrophenylsulphenyl (NPS) group into the tryptophan moiety at position 9 of ACTH(1\p=n-\24) greatly reduced both the potency and the capacity for maximal glycolytic response. It also virtually abolished cyclic AMP formation. In contrast, the capacity for a maximal steroidogenic response remained unimpaired in the NPS derivative, although steroidogenic potency was reduced to 0\m=.\4%of that of ACTH(1\p=n-\24).
Replacement of the tryptophan moiety with phenylalanine had intermediate inhibitory effects on glycolysis and steroid output; replacement with alanine virtually abolished both these responses. Replacement of arginine in position 8 with lysine in the Phe9 analogue caused a fifty-fold increase in glycolytic potency, but rendered it steroidogenically inactive. Cyclic AMP production was abolished in the Ala9 analogue and greatly impaired in the Phe9 and Lys8,Phe9 analogues. Replacement of the glycine moiety in position 10 with l-alanine, d-alanine, \ g = b \ \ x = r e q -\ alanine or \g=a\-aminoisobutyric acid had little or no effect on steroidogenic or glycolytic capacity, although potency was reduced with all substitutions excepting l-alanine.
Vasoactive intestinal peptide, which contains homologies with positions 3, 7, 15 and 16 of ACTH, proved completely inactive in dispersed mouse adrenal cells under our experimental conditions, in contrast to human parathyroid hormone(1\p=n-\34)(hPTH (1\p=n-\34)) which contains homologies with positions 3, 4, 5, 9 and 11 and was steroidogenic at the lowest concentration tested (0\m=.\1nmol/l), eliciting an eleven-fold increase in steroid production, a response which might be physiologically relevant. It induced near maximal steroidogenesis at a concentration of 10 nmol/l, without affecting cyclic AMP production, and stimulated glycolysis at concentrations above 10 nmol/l, accompanied by a slight rise in cyclic AMP levels. (Mcllwain, Anguiano & Cheshire, 1951; Wollenberger, 1955; Dittmann & Herrmann, 1970; Benjamin & Verjee, 1980) , tumour cells (Warburg,Bauer & Pease, 1979) , erythrocytes (Rodbell, 1966) and endocrine tissues (Hamberger & Ahrén, 1967; Birmingham, Huberman & Riven, 1968) . In the ovary the process is stimulated by luteinizing hormone and follicle-stimulating hormone, and in the adrenal gland by adrenocorticotrophin (ACTH) . In earlier work from this laboratory, ACTH was found to cause a three-to sixfold increase in lactic acid output from the mouse adrenal, an effect which was also elicited by cyclic AMP (cAMP). The response to ACTH and cAMP were dosedependent and usually paralleled steroid production by the gland (Bartova & Birmingham, 1971a) . Exogenous calcium was required for the glycolytic response to ACTH, but not to cAMP or dibutyryl cAMP (dbcAMP) (Birmingham & Bartova, 1973) . The glyco¬ lytic response to ACTH and dbcAMP could also be demonstrated in suspensions of mouse adrenal cells (Hinson & Birmingham, 1985 The crude cell suspension was filtered on a nylon gauze into two polypropylene centrifugation tubes. The cells were washed twice by centrifugation at 25 g for 2 min at room temperature. The final pellet was further purified by layering onto 5 ml 5% (w/v) KRBG-BSA and allowing sedimentation under gravity for 30 min at 4°C. The purified cells (0-5 ml) were preincubated in a 10 ml Teflon beaker under 95% 02-5% C02 for 1 h at 37°C with gentle oscillation. The preincubated cells were again washed twice with KRBG-BSA by centrifu¬ gation at 25 g for 2 min. The loose cell pellets were diluted with KRBG so that they contained 0-3% BSA (final volume 8-10 ml). Trypan blue (0-5%) was added to a small sample and the cells were counted in a haemocytometer. A yield of 300 000-500 000 cells/ml was normally obtained.
Incubation with peptides
The peptide diluent used was 0-05% (w/v) BSA in isotonic saline (pH 3-5) adjusted with HC1 (1 mol/1). Aliquots of diluted cell suspension (0-5 ml) were added to 10 ml Teflon beakers containing 005 A.) . For the estimation of corticosterone, the samples were washed with petroleum ether followed by extraction with dichloromethane. The phases of the emulsion were separated as described previously (Hinson & Birmingham, 1985) . The extracts were washed with NaOH (0-1 mol/1), and corticosterone, the major steroid produced by the mouse adrenal, was measured by fluorimetry (Zenker & Bernstein, 1958) .
RESULTS

Nitrophenylsulphenyl-ACTH
The analogue NPS-ACTH containing an O-nitrophenylsulphenyl substitution in the Trp9 residue of ACTH(l-24) was added to adrenocortical cells at concentrations ranging from 1 nmol/1 to 10µ 1/1. Unmodified ACTH(l-24) was tested at concen¬ trations of 0-1-10 nmol/1. The results revealed a marked disparity between the glycolytic and steroido¬ genic effects of the analogue (Fig. 1) . The analogue produced the same maximal steroidogenic response as ACTH(l-24) at high concentrations, but was not capable of maximal glycolytic stimulation at any con¬ centration tested. The maximal glycolytic activity obtained with NPS-ACTH was only about one-third that elicited by ACTH(l-24). The dose-response curves for both steroidogenesis and glycolysis were shifted to the right. The pooled log potency ratio for six assays from these experiments, calculated as described by Saffran & Schally, (1955) , was -2-39 + 0-118 for the steroidogenic response, denot¬ ing a potency of 0-41 % with fiducial limits of 0-23 and 0-71%. The glycolytic response, when it was not absent or too shallow to fulfill the bioassay require¬ ments for parallelism, gave a log potency ratio of -3-33 + 0-27, corresponding to a potency of 0-04% and fiducial limits of 001 and 017%.
The formation of cAMP in the experiment depicted in Fig. 1 is shown in Fig. 2b , and that of a second experiment, in which the concentration of NPS-ACTH ranged from 01 to 100 nmol/1, in Fig. 2a (Fig. 4) . 
Substitution of Gly10
Effects of replacement of the glycine residue in position 10 were examined utilizing analogues of ACTH(1-18)-NH2, a fragment which has been found to be nearly as effective as ACTH(l-24) in stimulating lactic acid and steroid production at concentrations of 0-1-10 nmol/1 (Hinson & Birmingham, 1987) . The effects of L-alanine, D-alanine, ß-alanine and aaminoisobutyric acid in position 10 are depicted in Fig. 5 . Replacement of glycine with L-alanine had no effect on glycolysis, although steroidogenic potency was reduced. Both responses were impaired with all other derivatives. The log potency ratios for L-alanine Rafferty, Zanelli, Rosenblatt & Schulster (1983) for hPTH.
As seen from the results depicted in Fig. 6 , VIP, examined over a range of lOnmol/1-0-1 mmol/1, increased neither corticosterone nor lactic acid pro¬ duction by dispersed mouse adrenal cells. In contrast, hPTH(l-34) was capable of inducing near maximal increases in both parameters, although the doseresponse curve for corticosterone differed greatly from that for lactic acid (Fig. 7) was barely stimulated by hPTH at 10 nmol/1 and was still increasing at lOpmol/l, the highest concen¬ tration tested. The production of cAMP in this exper¬ iment is depicted in Fig. 8 (Bartova & Birmingham, 1971a (Schwyzer, 1982 (Bartova & Birmingham, I91la,b; Hum, Barta-Bartova & Birmingham, 1981) .
